Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Disccath LLC currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. This portfolio is distributed across 2 distinct examiners and 2 distinct art units. The parity between the number of examiners and art units suggests a prosecution landscape where each matter is handled by a different individual in a different unit. This diversification requires the applicant to adapt to multiple sets of examiner preferences simultaneously.
The busiest examiner for this portfolio is BOECKELMAN, JACOB A, who is responsible for 1 pending office action. Because the total number of pending office actions is 2, this examiner handles 1 of the active actions. Practitioners should prepare for varied examiner perspectives given the 2 distinct examiners involved. The presence of 2 distinct art units indicates that the company's biotechnology interests are being evaluated under different technical focuses within the USPTO. The strategy must account for these separate Biotechnology & Pharmaceuticals art unit environments.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARRISON, SAMUEL JOSEPH | 1 | 69.4% | +38.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17426858 | MEDICAL DELIVERY DEVICE AND METHOD FOR DELIVERING THERAPEUTIC AGENTS DIRECTLY INTO THE ANNULUS FIBROSUS OF AN INTERVERTEBRAL DISC | MARRISON, SAMUEL JOSEPH | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17426858 | MEDICAL DELIVERY DEVICE AND METHOD FOR DELIVERING THERAPEUTIC AGENTS DIRECTLY INTO THE ANNULUS FIBROSUS OF AN INTERVERTEBRAL DISC | MARRISON, SAMUEL JOSEPH | 3783 | §103 | Final Rejection | — | Pending | Jul 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDisccath LLC has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Samuel Joseph Marrison has the most, with 1 of Disccath LLC's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.